All News about Orphazyme A/S ADR
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
NASDAQ:ORPH Investor Notice: Deadline on September 7, 2021 in Lawsuit Against Orphazyme A/S
August 26, 2021
Via SBWire
Topics
Lawsuit
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_84.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_90.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_3.jpeg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1574.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_264.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/microscope.trust-tru-katsande-6q5qg8iigro-unsplash.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_263.png)
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_361.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210802005843/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_360.jpg)
NASDAQ: ORPH Investor Notice: Lawsuit Alleges Securities Laws Violations by Orphazyme A/S
July 28, 2021
Via SBWire
Topics
Lawsuit
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20210720005225/en/478343/5/GPM_Logo_Colo.jpg)
![](https://mms.businesswire.com/media/20210719005062/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20210717005002/en/892103/4/5148087_5143434_5143056_5141180_5137515_Rosen-logo.jpg)
![](https://mms.businesswire.com/media/20210717005006/en/765953/5/Close_Up_Logo_HD_Blue.jpg)
![](https://mms.businesswire.com/media/20210716005355/en/478343/5/GPM_Logo_Colo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20210716005397/en/805853/5/Robbins_LLP.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/pharma-stocks.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.